A Point of Contention

February 21, 2017

Microneedling—also known as collagen induction therapy (CIT)—is a skin treatment in which tiny needles penetrate the skin in order to stimulate the production of collagen and other growth factors. It is relatively inexpensive, produces visible results with little chance of complications, and is easy to perform, so it appeals to both medical aesthetic and medical spa professionals and patients. However, although this treatment is simple, the legal issues surrounding it are not, so it is important that you understand why microneedling is such a controversial topic and how the legal view of it is evolving.
Treatments that break the outer layer of the patient’s skin are typically considered to be medical in nature. You might think that this automatically makes microneedling a medical procedure, but it is actually very difficult to judge if the skin is being broken when you are dealing with needles of this size. It can vary from patient to patient and depend on the part of the body being treated and the amount of pressure being applied.
Read more at American Spa magazine >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Retatrutide Phase 3 Trial: Adults With Type 2 Diabetes Lost Average of 50 Pounds
    • Medical Marketing Whiz Recognized With Healthcare Digital Marketing Excellence Award
    • Allergan Presents Early Data on Skin Quality Treatments for Patients Taking Weight-Loss Medications
    • ValueCap Becomes Silver Vendor Affiliate with the American Med Spa Association
    • FDA Warning Letter Signals Increased Scrutiny of the Medical Necessity Exception for Compounded GLP-1s